Home › Funds › Palo Alto Investors LP › PYXS
Palo Alto Investors LP position in PYXS
PYXIS ONCOLOGY INC · Health Care
Palo Alto Investors LP reported holding 864,277 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.30% of its reported portfolio and ranking #40 among its reported holdings. Palo Alto Investors LP has disclosed PYXS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's PYXS position evolved
Palo Alto Investors LP first disclosed a stake in PYXS in Q3 2024 at 170,000 shares (US$624K). The position peaked in Q2 2026 at 864,277 shares, worth US$2.6M. Across 9 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 864,277 shares valued at US$2.0M. Notable position changes include a 510% increase in Q4 2024 (shares fell 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 170.00K | $623.90K | New |
| Q4 2024 | 1.04M | $1.62M | Add |
| Q1 2025 | 1.04M | $1.02M | Hold |
| Q2 2025 | 1.04M | $1.14M | Hold |
| Q3 2025 | 1.04M | $2.30M | Hold |
| Q4 2025 | 1.04M | $1.19M | Hold |
| Q1 2026 | 1.01M | $1.48M | Reduce |
| Q2 2026 | 864.28K | $2.60M | Reduce |
| Q3 2026 | 864.28K | $2.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 41 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$36.2M), BVF INC/IL (US$27.6M), PFIZER INC (US$20.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 15.54M sh · $36.21M · Q3 2026
- BVF INC/IL 11.83M sh · $27.55M · Q3 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 1.25M sh · $2.91M · Q3 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Empery Asset Management, LP 1.00M sh · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K sh · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $761.47K · Q3 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held PYXS?
Palo Alto Investors LP has disclosed PYXS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Palo Alto Investors LP's current position in PYXS?
As of Q3 2026, Palo Alto Investors LP holds 864.28K shares of PYXS (PYXIS ONCOLOGY INC), valued at $2.01M, representing 0.30% of its reported portfolio and ranking #40.
Has Palo Alto Investors LP been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in PYXS. The position peaked in Q2 2026 at 864.28K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, BVF INC/IL, PFIZER INC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.